检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:马江伟 乔增勇[1] 张立[1] 曹华[1] 陶元[1] 刘化进[1] 金顶红[1] 朱翠清[1]
机构地区:[1]上海交通大学附属六院奉贤分院心内科,上海市201400
出 处:《中国基层医药》2010年第16期2176-2178,共3页Chinese Journal of Primary Medicine and Pharmacy
摘 要:目的 观察不同剂量阿托伐他汀对经皮冠脉内支架植入术(PCI)术后血清单核细胞趋化蛋白-1(MCP-1)、白细胞介素-10(IL-10)和高敏C反应蛋白(hs-CRP)水平的影响. 方法 选择PCI术后冠心病患者93例,按数字表法随机分成三组,每组31例,三组分别于术后给予阿托伐他汀10 mg、20 mg和40 mg口服,每天1次,持续服药1周以上,于术前及术后24 h、1周分别采集患者静脉血,测定MCP-1、IL-10和hs-CRP水平. 结果 三组术后24小时血清hsCR、MCP-1、IL-10水平较术前明显升高(t=7.231、9.516、3.612、8.254、9.365、4.125、8.473、8.342、4.106,均P<0.01);术后1周,三组hsCR、MCP-1水平较术后24 h明显降低(t=5.204、5.651、3.251、4.174、5.301、4.761,均P<0.01);术后1周,三组血清hsCR、MCP-1、IL-10、MCP-1/IL-10水平间差异均有统计学意义(F=27.625、43.396、3.486、44.961,均P<0.01);经直线相关分析,hs-CRP、MCP-1水平和MCP-1/IL-10比值与阿托伐他汀剂量呈负相关关系(hs-CRP:r=-0.617;MCP-1:r=-0.682;MCP-1/IL-10:r=-0.584,均P<0.01),IL-10与阿托伐他汀剂量无相关关系(r=0.138,P=0.187). 结论 阿托伐他汀可降低PCI术后患者血清hs-CRP和MCP-1水平,其剂量与hs-CRP和MCP-1水平呈负相关.Objective To Discuss the impacts of different dosage of atorvastatirs on serum hsCRP,IL-10 and MCP-1 levels on post-intervention patients with coronary stenting. Methods 93 post-intervention patients with coronary stenting were selected and randomly divided into 3 groups.Each group took different dosage of oral atorvastatins after the operation for more than one week.The dosage for each group was 10 mg,20 mg and 40 mg,respectively.Each patient was phlebotomized for three times,which are 24 hours before the operation,24 hours after the operation and one week after the operation.Serum MCP-1,IL-10 and hs-CRP levels were measured by enzyme linked immunosorbent assay(ELISA)and immunoturbidimetry(ITM). Results Serum hs-CRP and MCP-1 levels of post-intervention patients were significantly higher than those of pre-intervention.This illustrated that the serum hsCRP and MCP-1 levels were closely related to PCI.Serum hs-CRP and MCP-1 levels decreased in those patients one week after operation which proves they are negatively correlated with the dosage of atorvastatins.There was no statistic evidence to prove the correlation between different dosage of atorvastatins and the level of serum IL-10.The ratio of MCP-1/IL-10 at 24h post-intervention patient was significantly higher than pre-intervention,which proves the ratio was negatively correlated with the dosage of atorvastatins. Conclusion Atorvastatins decreases serum MCP-1 and hs-CRP levels after PCI.Serum MCP-1 and hs-CRP levels were negatively correlated with the dosage of atorvastatins.
关 键 词:血管成形术 经腔 经皮冠状动脉 C反应蛋白质 单核细胞趋化蛋白质类 白细胞介素10 阿托伐他汀
分 类 号:R541[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222